“We are the world’s engine of enzyme development”

Just recently the renowned nutrition and health company DSM introduced the new enzyme Balancius onto the European market. “It’s the first enzyme targeting dead cells and unlocking their nutritional potential,” says DSM vice president Enzymes and Eubiotics Sebastian Marten. He continues: “This is an absolute breakthrough innovation and we are very bold about this.” In the wake of DSM’s launch of it’s new enzyme Balancius at the European symposium on poultry nutrition in Gdanks, Pou